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cme.ctsnetjournals.orgdoi:10.1016/j.jtcvs.2006.01.065bjectives: This study analyzes the results of the arterial switch operation for
ransposition of the great arteries in member institutions of the European Congenital
eart Surgeons Association.
ethods: The records of 613 patients who underwent primary arterial switch
perations in each of 19 participating institutions in the period from January 1998
hrough December 2000 were reviewed retrospectively.
esults: A ventricular septal defect was present in 186 (30%) patients. Coronary
natomy was type A in 69% of the patients, and aortic arch pathology was present in
0% of patients with ventricular septal defect. Rashkind septostomy was performed in
5% of the patients, and 69% received prostaglandin. There were 37 hospital deaths
operative mortality, 6%), 13 (3%) for patients with an intact ventricular septum and 24
13%) for those with a ventricular septal defect (P  .001). In 36% delayed sternal
losure was performed, 8% required peritoneal dialysis, and 2% required mechanical
irculatory support. Median ventilation time was 58 hours, and intensive care and
ospital stay were 6 and 14 days, respectively. Although of various preoperative risk
actors the presence of a ventricular septal defect, arch pathology, and coronary anom-
lies were univariate predictors of operative mortality, only the presence of a ventricular
eptal defect approached statistical significance (P .06) on multivariable analysis. Of
arious operative parameters, aortic crossclamp time and delayed sternal closure were
lso univariate predictors; however, only the latter was an independent statistically
ignificant predictor of death.
onclusions: Results of the procedure in European centers are compatible with those in
he literature. The presence of a ventricular septal defect is the clinically most important
reoperative risk factor for operative death, approaching statistical significance on
ultivariable analysis.
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Dfter its introduction by Jatene and colleagues1 in the
early 1980s, as techniques in myocardial preserva-
tion improved and experience in coronary and con-
enital cardiac surgery accumulated, the arterial switch op-
ration (ASO) evolved into the primary modality for
reating transposition of the great arteries (TGA), by and
arge replacing the Mustard and Senning operations2-4
ore recently, excellent results of the ASO have been
eported from individual centers or collaborate studies5-8
perative mortality for simple TGA is reported in the range
f 2% to 7%, an impressive improvement compared with
he mortality of approximately 15% found in earlier stud-
es.3,5-13 Risk factors for operative mortality have inclu
he presence of a ventricular septal defect (VSD), older age
t repair, coexisting anomalies, and anomalous or unusual
oronary patterns.3,11,12,14-18
Although individual centers have reported excellent re-
ults,6,8,13,19,20 the outcome of the ASO across Europ
enters has not been studied. Therefore we sought to ana-
yze the collective experience of participant centers of the
uropean Congenital Heart Surgeons Association (ECHSA)
n the current era, with an emphasis on characteristics of the
atient population, associated anomalies, surgical results,
nd analysis of risk factors for adverse outcome.
ethods
he medical records of 613 patients with TGA who underwent
rimary ASO in each of the 19 participating ECHSA centers
etween January 1998 and December 2000 were reviewed retro-
pectively (Figure 1). Patients with complex TGA (TGA with 
nd pulmonary stenosis or the Taussig-Bing heart) were excluded.
emographic, functional, and interventional parameters were eval-
ated, including age, sex, weight, gestational age, coronary anatomy,
ssociated lesions, the degree of cyanosis, use of prostaglandin infu-
ion, preoperative Rashkind balloon septostomy, preoperative inotro-
ic support, mechanical ventilation and dialysis, and other associ-
ted morbidities. Associated procedures and operative variables
lowest temperature and aortic crossclamp and circulatory arrest
imes) were recorded. Postoperative outcome parameters (open
ternum, duration of mechanical ventilation, use of mechanical
upport, and length of intensive care unit [ICU] and hospital stay)
ere also noted.
Hospital mortality was defined as death during the operation or
ithin 30 days of the operation, according to the definition used in
he ECHSA’s database (now the European Association of Cardio-
horacic Surgery database). The univariate association between
isk factors and postoperative outcome was assessed by using
ither a 2 test for categoric risk factors or a t test (or a Mann-
hitney test) for continuous risk factors. A univariate logistic
egression model was also used to report the univariate odds for
eath along with 95% confidence intervals (CIs), and the Pearson
orrelation coefficient was used for other postoperative variables.
hose risk factors that were found to be significant were then
ested simultaneously in a multivariate logistic regression model.
Analyses were carried out with appropriate statistical softwareStata version 6.0; Stata Corp, College Station, Tex).
34 The Journal of Thoracic and Cardiovascular Surgery ● Septeesults
atient age at the time of the operation ranged from 0 days
o 22 months (median, 10 days; Figure 2), and w
anged from 1.46 to 14.0 kg (median, 3.42 kg). Gestational
ge was 28 to 43 weeks (median, 39 weeks), and 428 (70%)
f the patients were male. A VSD was present in 186 (30%)
atients, the remaining having an intact ventricular septum
IVS). The distribution of associated lesions is shown in
able 1, and coronary type according to the Yacoub 
ification14 is depicted in Figure 3.
Rashkind septostomy was performed in 450 (75%) pa-
ients, 387 (69%) received prostaglandin, 151 (30%) re-
uired preoperative ventilation, and 71 (13%) received ino-
ropic support. At the time of the operation, the median
owest temperature was 22°C and crossclamp time was 87
inutes, whereas in 177 (37%) patients a period of circu-
atory arrest was necessary to complete the procedure.
There were 37 (6%) hospital deaths, 13 among patients
ith TGA/IVS (3%) and 24 (13%) among patients with
GA/VSD (P  .001; odds ratio, 4.72; 95% CI, 2.34-9.49),
6% of which were due to cardiac causes (Table 2). In
f the patients, delayed sternal closure was performed, 8%
equired peritoneal dialysis, and 2% required mechanical
irculatory support. The median ventilation time was 58
Abbreviations and Acronyms
ASO  arterial switch operation
CI  confidence interval
ECHSA European Congenital Heart Surgeons
Association
ECMO  extracorporeal membrane oxygenation
ICU  intensive care unit
IVS  intact ventricular septum
TGA  transposition of the great arteries
VSD  ventricular septal defectFigure 1. Contributing centers.
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Dours, and ICU and hospital stays were 6 and 14 days,
espectively.
Univariate analysis of potential risk factors for operative
eath showed that VSD, coronary type overall, complex
oronary type and single coronary artery in particular, as-
ociated aortic pathology, increased aortic crossclamp time,
nd open sternum were associated with increased mortality,
hereas preoperative prostaglandin use was associated with
ecreased odds of death (Table 3). When the above
actors were included in a multivariate model, only the
resence of a VSD approached statistical significance (P 
06) as an independent risk factor for operative death
Table 4). On the other hand, leaving the sternum open
he end of the operation was a statistically significant inde-
endent risk factor for death (P  004; odds ratio, 5.4; 95%
I, 1.72-16.9; Table 4).
Multivariate analysis also showed that lower body
eight, longer aortic crossclamp time, and open sternum
ere statistically significant independent predictors of post-
perative acute renal failure. Aortic crossclamp time, the
igure 2. Age distribution. IVS, Intact ventricular septum; VSD,
entricular septal defect.se of circulatory arrest, and delayed sternal closure were
The Journal of Thoracictatistically significant determinants of duration of postop-
rative mechanical ventilation. Aortic crossclamp time was
he sole multivariate predictor for the use of mechanical
irculatory support (P  .05). Preoperative increased arte-
ial oxygen saturation, prostaglandin infusion, increased
ortic crossclamp time, and delayed sternal closure were
tatistically significant independent risk factors for pro-
onged ICU stay. Prolonged hospital stay was statistically
ignificantly associated with the presence of concomitant
ortic arch pathology, increased aortic crossclamp time,
irculatory arrest, and delayed sternal closure (Table 5
iscussion
he clinical characteristics of the patient population in this
tudy are similar to those generally found in anatomic repair
f TGA. Most patients are neonates with a median age of 10
ABLE 1. Distribution of associated lesions
ategory No. of patients (% of total)
VS 427 (70%)
Situs inversus 2 (0.4%)
CoA 2 (0.4%)
Hypoplastic arch 1 (0.2%)
SD 186 (30%)
Situs inversus 1 (0.5%)
Multiple 13 (6.9%)
CoA 21 (11.3%)
Hypoplastic arch 12 (6.4%)
Interrupted arch 3 (1.6%)
VS, Intact ventricular septum; VSD, ventricular septal defect; CoA, aortic
oarctation.Figure 3. Coronary type.
and Cardiovascular Surgery ● Volume 132, Number 3 635
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Days, with no difference between those with TGA/IVS and
hose with TGA/VSD. Interestingly, a number of patients
ad 1-stage ASO beyond 4 weeks of age (Table 2
igure 2). A recent report supports safe 1-stage repa
GA/IVS beyond 3 weeks (range, 21-185 days) of age.8 On
verage, however, ASO is not delayed in participating
CHSA centers. Of significant interest is the presence of
ssociated anomalies, particularly aortic arch pathology;
his was rare in patients with TGA/IVS but occurred in up
o 19.3% of patients with TGA/VSD, 2-fold higher than
reviously reported.7 Conversely, the incidence of unusu
oronary patterns was similar to that seen in the literature,
ith 69% of patients having type A and 9% having a single
oronary artery (Figure 3).2,14,21
Most procedures were performed without deep hypother-
ic circulatory arrest, which was used in 37% of the patients.
ecause the duration of deep hypothermic circulatory arrest
as variable, its use (for more than a few minutes to close the
trial septal defect) appears limited to cases with aortic arch
athology, yet did not appear to influence outcome (Tabl
Although duration of crossclamp time is similar to that
een in published reports, this factor was a univariate pre-
ictor of death (Table 3) and the sole multivariate pred
or the postoperative use of mechanical circulatory support
Table 5). However, the large overlap in crossclamp t
etween survivors versus nonsurvivors, as well as between
xtracorporeal membrane oxygenation (ECMO) and non-
CMO cases, precluded determination of useful upper or
ower cutoff crossclamp time values for mortality or the use
f ECMO. It is likely that aortic crossclamp time might
erve as a surrogate variable for a more complex procedure
r other factors.
The use of delayed sternal closure is comparably hig22
n some institutions delayed sternal closure was practiced
ABLE 2. Operative mortality
Dead Alive P value
VS (total) 13 (3%) 414 (97%) .001
SD (total) 24 (13%) 162 (87%)
VS (4 wk, n  52) 1 (2%) 51 (98%) .02
SD (4 wk, n  62) 9 (9%) 53 (98%)
VS (8 wk, n  36) 1 (3%) 35 (97%) .39, NS
SD (8 wk, n  50) 5 (10%) 45 (90%)
VS (4 wk, n  375) 12 (3%) 363 (97%) 1.0, NS
VS (4 wk, n  52) 1 (2%) 51 (98%)
VS (4 wk, n  375) 12 (3%) 363 (97%) 1.0, NS
VS (8 wk, n  36) 1 (3%) 35 (97%)
SD (4 wk, n  124) 15 (12%) 109 (88%) .64, NS
SD (4 wk, n  62) 9 (15%) 53 (85%)
SD (4 wk, n  124) 15 (12%) 109 (88%) .79, NS
SD (8 wk, n  50) 5 (10%) 45 (90%)
S, Nonsignificant.outinely, whereas in others selective use was recorded. a
36 The Journal of Thoracic and Cardiovascular Surgery ● Septed
f
.
r
herefore in this retrospective study it was not possible to
istinguish cases in which delayed sternal closure was en-
irely “elective” from those in which it was necessary be-
ause of mediastinal-cardiac edema.
Overall surgical outcome is comparable with reported re-
ults, with an overall operative mortality of 6%.5-8,10-13 There
as a significant difference in mortality between patients with
GA/IVS (3%) and patients with TGA/VSD (13%). The rea-
on for this clinically significant difference remains unclear.
Of note is that high center volume was not a statistically
ignificant factor for predicting lower mortality. Univariate
nalysis did show an increased risk of death for VSD and
ertain types of coronary anatomy, arch pathology, and in-
reased crossclamp time, but these other factors did not retain
tatistical significance on multivariable analysis, whereas the
resence of a VSD nearly achieved statistical significance
P  .06). Thus although one could speculate that excess
ortality in patients with TGA/VSD pertains to increased
rossclamp time (which in itself is a univariate predictor of
perative mortality) or to an excess of patients with arch
athology or abnormal coronary arteries, multivariate anal-
sis did not support this hypothesis. Perhaps the presence of
VSD serves as a marker or surrogate variable for other
nterrelated undefined factors that lead to increased mortal-
ty, but in any case it is unequivocal that VSD presence is a
linically significant and easily identifiable risk factor for
perative death in our series.6,7,12,20
Clearly, delayed sternal closure as an operative outcome
ariable is associated with increased mortality. Interest-
ngly, 52 patients with IVS who were older than 4 weeks of
ge (of which 36 were older than 8 weeks of age) underwent
 primary ASO (Table 2 and Figure 2) with mor
omparable with that of the IVS subgroup of patients less
han 4 weeks of age and significantly less than that of the
atients with TGA/VSD aged more than 4 weeks (Tabl
f course, patients with IVS in these age cohorts who had
-stage repair have not been included in this report.
With regard to the use of ECMO and dialysis, as well
s length of ICU and hospital stay, these parameters are
ithin the spectrum of what is reported in the litera-
ure.8,12,19 Multivariate analysis of risk factors for th
arameters points to the clinically intuitive factors, such
s increased crossclamp time, further underscoring the
eed to minimize ischemic time to improve outcome.
In summary, our study shows that results of ASO for
GA in participating ECHSA centers are comparable
ith those seen in the literature, although with signifi-
antly higher operative mortality for TGA/VSD com-
ared with TGA/IVS. Although the presence of VSD was
he only preoperative factor that approached statistical
ignificance on multivariable analysis as a predictor of
ortality, the finding on univariate analysis that coronarynomalies and arch pathology are associated with in-
mber 2006
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DABLE 3. Univariate analysis of risk factors for operative death
isk factors Dead Alive Odds ratio (95% CI) P value
ex .15, NS
Male 22 (5%) 407 (95%) 1.0
Female 15 (8%) 169 (2%) 1.64 (0.83-3.23)
estation age (wk)
Median (range) 38 (36-40) 39 (28-43) 0.87 (0.73-1.05) .15, NS
ge at operation (days)
Median (range) 9 (2-507) 10 (0-660) 1.0 (0.99-1.003) .98, NS
eight at operation (kg)
Mean (SD) 3.42 (1.08) 3.52 (0.95) 0.87 (0.57-1.33) .52, NS
VS 13 (3%) 414 (97%) 1.0 .001
SD 24 (13%) 162 (87%) 4.72 (2.34-9.49)
oronary type
A 13 (3%) 369 (97%) 1.0 .003
D 6 (7%) 78 (93%) 2.18 (0.80-5.92) .12, NS
Single coronary 5 (11%) 42 (89%) 3.38 (1.15-9.95) .03
Other 6 (16%) 32 (84%) 5.32 (1.89-14.9) .002
ultiple VSDs .10, NS
No 29 (5%) 541 (95%) 1.0
Yes 2 (15%) 11 (85%) 3.39 (0.72-16.01)
ortic pathology (CoA, hypoplastic, interrupted arch) .003
No 30 (6%) 490 (94%) 1.0
Any 6 (21%) 23 (79%) 4.26 (1.61-11.2)
aO2 (%)
Median (range) 84 (25-98) 80 (25-98) 1.01 (0.98-1.05) .40, NS
notropes .40, NS
No 25 (5%) 467 (95%) 1.0
Yes 2 (3%) 69 (97%) 0.54 (0.12-2.33)
entilation .58, NS
No 21 (6%) 338 (94%) 1.0
Yes 7 (5%) 144 (95%) 0.78 (0.32-1.88)
ashkind .26, NS
No 12 (8%) 144 (92%) 1.0
Yes 24 (5%) 426 (95%) 0.66 (0.32-1.36)
rostaglandin .03
No 14 (8%) 158 (92%) 1.0
Yes 14 (4%) 373 (96%) 0.42 (0.19-0.91)
owest temperature (ºC)
Median (range) 22 (13.2-35) 22 (13-36) 0.97 (0.89-1.05) .43, NS
ortic crossclamp time (min)
Median (range) 113 (72-330) 85 (27-348) 1.01 (1.008-1.02) .001
pen sternum .001
No 11 (3%) 383 (97%) 1.0
Yes 25 (12%) 192 (88%) 4.53 (2.18-9.41)
orbidity .51, NS
No 30 (6%) 477 (94%) —
Yes 0 (0 %) 7 (100%)
irculatory arrest time
0 min 16 (5%) 287 (95%) 1.0 .74, NS
1-10 min 5 (5%) 103 (95%) 0.87 (0.31-2.43) .79, NS
10 min 5 (7%) 64 (93%) 1.40 (0.49-3.96) .52, NS
I, Confidence interval; NS, nonsignificant; SD, standard deviation; IVS, intact ventricular septum; VSD, ventricular septal defect; CoA, aortic coarctation;
aO2 , arterial oxygen saturation.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 3 637
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Dreased mortality is clinically relevant. Furthermore, the
nding of a univariate association of increased cross-
lamp time and adverse outcome calls for increased ef-
orts to limit ischemic time as much as possible.
ABLE 4. Multivariate analysis of univariate predictors for
perative deaths
isk factors
Multivariate odds
ratio (95% CI) P value
VS 1.0
SD 2.71 (0.96-7.68) .06, NS
oronary type A 1.0 .47, NS
Coronary type D 1.56 (0.49-4.95) .45, NS
Single coronary 2.03 (0.55-7.47) .28, NS
Other 2.57 (0.67-9.76) .16, NS
ortic pathology (CoA, hypoplastic,
interrupted arch)
.42, NS
No 1.0
Any 1.75 (0.45-6.83)
rostaglandin .92, NS
No 1.0
Yes 0.95 (0.36-2.49)
ortic crossclamp time 1.0 (0.99-1.01) .21, NS
pen sternum .004
No 1.0
Yes 5.4 (1.72-16.9)
I, Confidence interval; IVS, intact ventricular septum; VSD, ventricular
eptal defect; NS, nonsignificant; CoA, aortic coarctation.
ABLE 5. Multivariate analysis of univariate predictors fo
utcome parameter Postoperative
dialysis
Postoperative m
ventilatisk factors
ex NS NS
estation age (wk) NS NS
ge at operation (days) NS NS
eight at operation (kg) .005 NS
VS/VSD NS NS
oronary type NS NS
ultiple VSDs NS NS
ortic pathology NS NS
reoperative SaO2 (%) NS NS
notropes NS NS
reoperative ventilation NS NS
ashkind NS NS
reoperative prostaglandin NS NS
owest temperature (ºC) NS NS
ortic crossclamp time (min) .001 .00
pen sternum .001 .00
orbidity NS NS
irculatory arrest time NS NS
1-10 min NS .01
10 min NS NS
CMO, extracorporeal membrane oxygenation; ICU, intensive care unit; NS
aO2 , arterial oxygen saturation.
38 The Journal of Thoracic and Cardiovascular Surgery ● SepteThis is a retrospective multi-institutional study with
ignificant variation in the number of patients contributed
y each center. Furthermore, there was no uniform ap-
roach regarding surgical management, technique, and
ostoperative care protocols. An important limitation re-
ains that this study was not designed to assess long-
erm follow-up.
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